You are here

About the Journal

New Horizons in Translational Medicine (NHTM) is the official publication of the European Society for Translational Medicine. NHTM aims to keep scientific community informed about latest developments and updates in translational research field. NHTM publishes high quality manuscripts covering all aspects of translational medicine from benchside, bedside and community medicine. NHTM equally considers manuscripts on all aspects of research and development in biotech and pharma industries. Selection of papers for publication is based on their scientific excellence, distinctive contribution to knowledge (including methodological development) and their importance to the translational medicine field. NHTM also publishes invited review articles from experts in the field.

Topics suitable for publication in NHTM include:

  • Benchside Studies (which advance the pathophysiological knowledge of clinical conditions)
  • Bedside Studies (which provide valuable information about clinical conditions especially for benchside researchers to develop new/to test a hypothesis in their research areas)
  • Biomarkers & Novel Diagnostics (novel studies/findings in biomarkers and diagnostic field including development, regulatory aspects, consensus/position articles, personalised medicine approaches)
  • Disease Modelling (models and approaches to better understand clinical conditions)
  • Data Management & Clinical Bioinformatics (Studies with novel approaches, technologies and methodology for effective data mining and management are considered)
  • Omics Sciences (Studies related to Genetics, Proteomics, Metabolomics and related areas)
  • Translating Vaccines (all aspect of vaccines research & development, though special focus on translational studies)
  • Clinical Epidemiology & Public Health (studies and approaches which provide new horizon for bench, bedside & Academia & Industry to develop new hypothesis/concepts)
  • Translating Rare/Orphan Diseases (topics which provide novel insight into orphan disease area are considered)
  • Early Drug Discovery and Development

 

Submit your paper via EES - ELSEVIER

Start e-learning!

Create your username and password to access the UEMS-ACCME accredited e-Learning modules.

Join now and receive:

  • eAlerts when new content is available
  • Updates on next courses

Register

E-alert

Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

Search this website

Search form

Share